01 Aug
Researchers analyzed cancer incidence and mortality rates across generations and found a significant increase in many types of cancer among Generation X and millennials.
Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue that, once begun, is irreversible.
For many p...
Cancer rates are rising among Gen Xers and millennials, a new study reports.
Successively younger generations are more frequently being diagnosed half of the 34 known
Prior studies have found that statin meds can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same.
A team led by Katherine McGlynn...
A new AI-driven blood test could improve detection of liver cancer, which is one of the most fatal cancers because early diagnosis is difficult.
The t...
A new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2 clinical trial.
The combo the...
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
The vaccine could help liver cancer patients live longer, as fewer than one in 10 survive five y...
Dr. Gary Gibbon didn't have long to live.
A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently d...
Cancer deaths continue to decline in the United States, with more than 4 million deaths prevented since 1991, a new report shows.
But more people are developing cancers than ever, making the dreaded disease a continued threat to human health, according to the
The risk of developing liver cancer appears to be rising with each successive generation of Mexican-Americans, especially men, a new report finds.
"Liver cancer is becoming a growing concern among Latinos, underscoring the importance of comprehending the factors driving ...
There are plenty of reasons to steer clear of sugary drinks, and new research highlights yet another one: Women who drink sodas and other sweetened drinks have a higher risk of developing liver cancer and chronic liver disease.
Looking at data on nearly 100,000 women, r...
Cancer death rates among Hispanic Americans have declined in general over the past two decades, but for certain cancers the outlook has only gotten worse, a new study finds.
First, the good news: Thanks to improvements in screening, diagnosis and treatment -- and a decli...
A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.
The combo -- atezolizumab (Tecentriq) and bevacizumab (Avastin) -- reduced risk of cancer recurrence or ...
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
While Medicare payments in the first year after diagnosis with hepatocellular carcinoma (HCC) exceeded $65,000, out-of-pocket costs were more than $10,000,
A chemical called perfluooctane sulfate (PFOS) has been linked to the most common type of liver cancer, a new study indicates.
PFOS are used in a wide range of consumer and industrial products, and are referred to as "forever chemicals"because they break down very slowly...
Less than one-third of people with hepatitis C get treatment for this potentially deadly, but curable, infection within a year of their diagnosis, a new government report warns.
Spread by contact w...
Sodas and other sugar-sweetened drinks may raise a woman's odds of developing liver cancer, new research suggests.
A study of more than 90,000 postmenopausal women found that those who drank at least one sugar-sweetened beverage a day had a 78% higher risk, compared with...
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.
The study, of more than 700 cancer facilities nationwide, found that i...
President Joe Biden announced Wednesday that he is giving a new push to the cancer moonshot initiative that he first led during the Obama administration.
In his announcement, Biden said the program ...
Most American adults don't know that alcohol boosts cancer risk, but a majority support steps to increase awareness of the link, a new nationwide survey shows.
""It is important that people are made fully aware of the potential harms of alcohol so that they may make info...
When delivering a liver cancer diagnosis, Dr. Thomas Marron pulls no punches: "Liver cancer is one of the deadliest cancers," he tells patients.
Jeffrey Foster heard a similar message loud and clear when he was first diagnosed by another doctor with hepatocellular carcin...
Cancer remains a major killer, with 10 million deaths reported worldwide in 2019.
More than 23 million new cases were documented globally in 2019, according to researchers at the University of Washington School of Medicine.
By comparison, in 2010 there were 8.29 m...
It's clear that COVID-19 has killed many hundreds of thousands of people in the United States. Less clear is its impact on other health issues, which will be felt in the years to come.
Liver disease is projected to be one of those, with 8,000 additional deaths from
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...
Hispanic people in the United States have lower cancer rates than white people, but they are much more likely to develop certain preventable cancers.
"The good news is that overall cancer rates are lower in Hispanic people, but we are seeing very high rates of infectious...
Liver cancer is on the rise in rural America, but on a downswing in cities, new research shows.
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the fastest-growing cause of cancer deaths in the United States. It's rising at an annual rate of ne...
Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report.
The new findings are important, they noted, because immunotherapy doesn't typically work against microsatellite stable (MSS) colon cancer. These...